1. Home
  2. ORBS vs AKBA Comparison

ORBS vs AKBA Comparison

Compare ORBS & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eightco Holdings Inc.

ORBS

Eightco Holdings Inc.

HOLD

Current Price

$0.87

Market Cap

337.7M

Sector

N/A

ML Signal

HOLD

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$0.93

Market Cap

375.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORBS
AKBA
Founded
1966
2007
Country
United States
United States
Employees
9
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
337.7M
375.0M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ORBS
AKBA
Price
$0.87
$0.93
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.67
AVG Volume (30 Days)
20.9M
5.5M
Earning Date
04-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
93.94
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$0.88
52 Week High
$15.96
$4.08

Technical Indicators

Market Signals
Indicator
ORBS
AKBA
Relative Strength Index (RSI) 46.67 33.94
Support Level $0.76 $0.88
Resistance Level $1.28 $1.56
Average True Range (ATR) 0.13 0.07
MACD 0.00 0.00
Stochastic Oscillator 27.97 27.29

Price Performance

Historical Comparison
ORBS
AKBA

About ORBS Eightco Holdings Inc.

Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business. Corrugated Packaging Business manufactured and sold custom packaging for a wide products and through packaging helps customers generate brand awareness and promote brand image. Generate the substantial majority of revenues from inventory financing and inventory management services.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

Share on Social Networks: